Tag: tumor microenvironment modulation

Cancer researchers have unveiled an ambitious biological strategy that turns engineered bacteria into “exogenous organelle mimics”—living microscopic systems designed to ...

Gastric cancer may be exploiting a little-known metabolic molecule to disable the immune system, according to research from Keio University ...

Cancer immunotherapy has transformed treatment for some patients, yet many solid tumors remain protected by a hostile biological environment that ...

Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...

Head and neck squamous cell carcinoma (HNSCC) is among the world’s most challenging cancers, accounting for approximately 90% of malignancies ...

Lung cancer’s spread to bone is one of the most destructive stages of the disease, often causing severe pain, fractures, ...

Immune checkpoint blockade has reshaped modern oncology, but its success remains uneven. Drugs that disrupt the PD-1/PD-L1 pathway can produce ...

Pancreatic cancer may be one of the most difficult cancers to treat, but new research points to a microscopic event ...

A new early-stage clinical study reports that targeting tumor metabolism and immune recognition may offer a workable strategy for patients ...

A new viral-science report highlights fresh evidence that directly targeting oncogenic KRAS can prime the immune system to fight pancreatic ...